Tarpeyo Interactions
There are 571 drugs known to interact with Tarpeyo (budesonide), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 71 are major, 475 are moderate, and 25 are minor.
- View all 571 medications that may interact with Tarpeyo
- View Tarpeyo alcohol/food interactions (1)
- View Tarpeyo disease interactions (7)
Most frequently checked interactions
View interaction reports for Tarpeyo (budesonide) and the medicines listed below.
- Actemra (tocilizumab)
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Addyi (flibanserin)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- Andembry (garadacimab)
- atorvastatin
- baclofen
- carvedilol
- CellCept (mycophenolate mofetil)
- Farxiga (dapagliflozin)
- Gardasil 9 (human papillomavirus vaccine)
- Humira (adalimumab)
- hydralazine
- Jardiance (empagliflozin)
- Lexapro (escitalopram)
- losartan
- metformin
- Nucala (mepolizumab)
- omeprazole
- Otezla (apremilast)
- pantoprazole
- Rezdiffra (resmetirom)
- rosuvastatin
- spironolactone
- Tremfya (guselkumab)
- Wegovy (semaglutide)
Tarpeyo alcohol/food interactions
There is 1 alcohol/food interaction with Tarpeyo (budesonide).
Tarpeyo disease interactions
There are 7 disease interactions with Tarpeyo (budesonide) which include:
- hepatic impairment
- infections
- lactose intolerance
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- hyperadrenocorticism
Report options
QR code containing a link to this page
More about Tarpeyo (budesonide)
- Tarpeyo consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: glucocorticoids
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
